These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8251747)

  • 21. An Escherichia coli expression vector that allows recovery of proteins with native N-termini from purified calmodulin-binding peptide fusions.
    Wyborski DL; Bauer JC; Zheng CF; Felts K; Vaillancourt P
    Protein Expr Purif; 1999 Jun; 16(1):1-10. PubMed ID: 10336854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression and purification of an immunologically reactive His-BIV capsid fusion protein.
    Betemps D; Mallet F; Cheynet V; Baron T
    Protein Expr Purif; 1999 Apr; 15(3):258-64. PubMed ID: 10092485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preparation of a specific immunogen based on bacteriophage M13].
    Minenkova OO; Il'ichev AA; Kishchenko GP; Il'icheva TN; Khripin IuL; Oreshkova SF; Petrenko VA
    Mol Biol (Mosk); 1993; 27(3):561-8. PubMed ID: 7686250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
    Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. cDNA encoding a single-chain antibody to HIV p17 with cytoplasmic or nuclear retention signals inhibits HIV-1 replication.
    Tewari D; Goldstein SL; Notkins AL; Zhou P
    J Immunol; 1998 Sep; 161(5):2642-7. PubMed ID: 9725267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and characterization of human and mouse recombinant alpha-fetoproteins expressed in Escherichia coli.
    Boismenu R; Semeniuk D; Murgita RA
    Protein Expr Purif; 1997 Jun; 10(1):10-26. PubMed ID: 9179285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning, high-yield expression in Escherichia coli, and purification of biologically active HIV-1 Tat protein.
    Kirsch T; Boehm M; Schuckert O; Metzger AU; Willbold D; Frank RW; Rösch P
    Protein Expr Purif; 1996 Aug; 8(1):75-84. PubMed ID: 8812837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of gag and pol sequences from long-term survivors of human immunodeficiency virus type 1 infection.
    Huang Y; Zhang L; Ho DD
    Virology; 1998 Jan; 240(1):36-49. PubMed ID: 9448687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterologous expression of soluble, active proteins in Escherichia coli: the human estrogen receptor hormone-binding domain as paradigm.
    Nygaard FB; Harlow KW
    Protein Expr Purif; 2001 Apr; 21(3):500-9. PubMed ID: 11281726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
    Dis Markers; 1990; 8(3):162-3. PubMed ID: 2125537
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of nucleocapsid of HIV-1 in virus assembly.
    Dawson L; Yu XF
    Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant technology as an alternative to chemical peptide synthesis: expression and characterization of HIV-1 Rev recombinant peptides.
    Lepage P; Heckel C; Humbert S; Stahl S; Rautmann G
    Anal Biochem; 1993 Aug; 213(1):40-8. PubMed ID: 8238880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 p24-immunoglobulin fusion molecule: a new strategy for plant-based protein production.
    Obregon P; Chargelegue D; Drake PM; Prada A; Nuttall J; Frigerio L; Ma JK
    Plant Biotechnol J; 2006 Mar; 4(2):195-207. PubMed ID: 17177796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Production of recombinant proteins and their use in immunoblotting].
    Farkhutdinov MR; Galiullin FG; Davletov EG; Gabbasov ShF; Safin BN
    Vopr Med Khim; 1993; 39(3):60-2. PubMed ID: 8333196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.
    Fiorentini S; Marini E; Bozzo L; Trainini L; Saadoune L; Avolio M; Pontillo A; Bonfanti C; Sarmientos P; Caruso A
    Biopolymers; 2004; 76(4):334-43. PubMed ID: 15386266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression and large-scale purification of recombinant hamster polymorphic arylamine N-acetyltransferase as a dihydrofolate reductase fusion protein.
    Sticha KR; Sieg CA; Bergstrom CP; Hanna PE; Wagner CR
    Protein Expr Purif; 1997 Jun; 10(1):141-53. PubMed ID: 9179301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel carrier molecule for high-level expression of peptide antibiotics in Escherichia coli.
    Rao XC; Li S; Hu JC; Jin XL; Hu XM; Huang JJ; Chen ZJ; Zhu JM; Hu FQ
    Protein Expr Purif; 2004 Jul; 36(1):11-8. PubMed ID: 15177279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterologous gene expression in a membrane-protein-specific system.
    Turner GJ; Reusch R; Winter-Vann AM; Martinez L; Betlach MC
    Protein Expr Purif; 1999 Nov; 17(2):312-23. PubMed ID: 10545281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
    Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression in Pichia pastoris, fermentation and purification of HIV-1 CN54 Gag antigen].
    Hao YL; Ma MQ; Fu JJ; Li HS; Wang YJ; Liu Y; Wu L; Liu Y; Shao YM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun; 19(2):128-31. PubMed ID: 16027777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.